Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production and sale of needle-free jet injectors, both for humans and animals.

MIT injectors are licensed by Health Canada, are CE marked for sale in the European Union, and hold several other certifications around the world. MIT’s quality management system complies with the requirements of ISO 13485 and ISO 9001. MIT’s devices are currently sold around the world for various applications including injection of stem cells, hyaluronic acid and Botox.

MIT’s experience in the research and development of needle-free jet injectors dates back to 1978. Our technology and practicable applicability provide a distinct competitive edge. Unlike other types of needle-free injection systems available on the market, MIT's injectors function with a low pressure system that does not compromise on accuracy, efficiency or safety, and almost entirely eliminate the pain and discomfort caused by current-day injection systems. MIT’s injection platform is also highly customizable to tailor the injector to suit a specific application.